Blog
RSS FeedPosted by Michael Wonder on 25 Oct 2022
October Budget 2022-23: a no surprise budget for health
25 October 2022 - Medicines Australia welcomes tonight’s Budget which take steps towards addressing economic pressures and introduces new funding ...
Posted by Michael Wonder on 13 Oct 2022
Amgen's annual trends report finds competition created by biosimilars contributed $21 billion in US health care system savings
12 October 2022 - Ninth Edition of Amgen's Biosimilar Trends Report Examines the U.S. and Global Marketplace with Biosimilars. ...
Posted by Michael Wonder on 20 Jul 2022
The big squeeze?
20 July 2022 - With NHS England highlighting savings of £1.2 billion on medicines in three years coming from both ...
Posted by Michael Wonder on 13 Jul 2022
Biosimilar uptake accelerates in US—and so do the savings
13 July 2022 - Amgen's early view said health care savings from the use of these biologic therapies climbed to ...
Posted by Michael Wonder on 03 Jul 2022
NHS saves 1.2 billion pounds on medicines over three years
1 July 2022 - The NHS has saved taxpayers £1.2 billion in just three years, while securing cutting-edge treatments for ...
Posted by Michael Wonder on 21 Jun 2022
Medicare could’ve saved $3.6 billion by buying drugs at same prices as Mark Cuban’s online pharmacy, according to a new study
22 June 2022 - Medicare’s drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing ...
Posted by Michael Wonder on 25 May 2022
Medicare spending on drugs with accelerated approval
24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to ...
Posted by Michael Wonder on 19 Apr 2022
Prioritising reference products over biosimilars led to millions of missed savings for Part D
20 April 2022 - Medicare Part D plans missed out on between $84 million and $143 million in savings by ...
Posted by Michael Wonder on 29 Mar 2022
Budget 2022-23 – no ‘big bang’ announcements in health
29 March 2022 - Medicines Australia welcomes tonight’s Budget announcements for new PBS listings and on-going COVID-19 measures. ...
Posted by Michael Wonder on 29 Mar 2022
Record investment in the future of Australia's health system
29 March 2022 - The Australian Government is investing in a stronger health system as part of our plan for a ...
Posted by Michael Wonder on 19 Mar 2022
Final reconciliation of savings from side agreements for the full year 2021
18 March 2022 - TLV has presented the final reconciliation to the government of the outcome of the rebates in ...
Posted by Michael Wonder on 20 Feb 2022
Stabilising health care’s share of the GDP
19 February 2022 - Since the 1980s, policy makers and private health insurers have implemented various interventions aimed at “bending the ...
Posted by Michael Wonder on 26 Dec 2021
PBS expenditure and prescriptions report 2020-21
24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...
Posted by Michael Wonder on 17 Oct 2021
Recent trends in Medicaid spending and use of drugs with US Food and Drug Administration accelerated approval
8 October 2021 - In this cross-sectional study of 216 drugs granted accelerated approval from 1992 through 2020, relative to all ...
Posted by Michael Wonder on 08 Jul 2021
House report: drug companies spent more on buybacks, dividends than research
8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...